Fundraising Fox
/Companies
Sign in

ImmusanT

Cambridge, US · Founded 2010 · Delaware corporation · 2 known investors

Find your way into ImmusanT

Sign up to find every way you can get introduced to ImmusanT

  • Your email: who you already know at ImmusanT, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ImmusanT team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

ImmusanT works on scientific research into the mechanisms of celiac disease, collaborating with investigators from academic and medical research institutions. The company operates in the biotechnology and immunology field focused on this autoimmune condition.

BiotechHealthtech

Founders & leadership

ImmusanT was founded in 2010 by Leslie Williams.

LWLeslie Williams
Leslie WilliamsFounder
TD
Thomas DanielNamed on SEC filing
SG
Steven GillisNamed on SEC filing
TK
Thomas KoestlerNamed on SEC filing

Board

CG
Ceclia GonzaloBoard director
KF
Kevin FerroBoard director
CE
Craig EstwickBoard director
JS
Justin SunBoard director
SK
Sundar KodiyalamBoard director

Investors · 2

ARCH Venture PartnersreportedChicago · $50K – $250M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$32.7M disclosed across 2 of 3 rounds · 2011–2017

▶$19.9MraisedNov 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas DanielDirector
  • Leslie WilliamsExecutive Officer, Director
  • Ceclia GonzaloDirector
  • Kevin FerroDirector
  • Steven GillisDirector
  • Thomas KoestlerDirector
Offering amount
$39.9M
Amount sold
$19.9M
First sale
Nov 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.8MraisedDec 2014 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Craig EstwickDirector
  • Thomas KoestlerDirector
  • Justin SunDirector
  • Sundar KodiyalamDirector
  • Kevin FerroDirector
  • Leslie WilliamsExecutive Officer, Director
Offering amount
$12.8M
Amount sold
$12.8M
First sale
Dec 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

ImmunovantImmunovant is a clinical-stage immunology company developing targeted therapies based on anti-FcRn technology for people with autoimmune diseases.

Companies working in the same space as ImmusanT.

In the news

ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Diseaseprnewswire.com · Dec 2011

Frequently asked questions

What does ImmusanT do?
ImmusanT works on scientific research into the mechanisms of celiac disease, collaborating with investigators from academic and medical research institutions. The company operates in the biotechnology and immunology field focused on this autoimmune condition.
Who founded ImmusanT?
ImmusanT was founded by Leslie Williams in 2010.
Who are ImmusanT's investors?
ImmusanT's investors include Vatera Healthcare Partners, ARCH Venture Partners.
How much funding has ImmusanT raised?
ImmusanT has disclosed $32.7M raised across 2 of its 3 known rounds.
Where is ImmusanT headquartered?
ImmusanT is headquartered in Cambridge, US.